ZNTL
Zentalis Pharmaceuticals Llc
NASDAQ: ZNTL · HEALTHCARE · BIOTECHNOLOGY
$4.01
+1.26% today
Updated 2026-04-30
Market cap
$287.27M
P/E ratio
—
P/S ratio
7.13x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$1 – $7
Volume
2.2M
Zentalis Pharmaceuticals Llc (ZNTL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-49.50%
ROA
-24.50%
Debt/equity
0.15x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $14000.00 | $-21.07M | 100.00% | -169,878.57% | -150,478.57% |
| 2019 | $0.00 | $-45.66M | — | — | — |
| 2020 | $0.00 | $-117.84M | — | — | — |
| 2021 | $0.00 | $-158.72M | — | — | — |
| 2022 | $0.00 | $-236.81M | — | — | — |
| 2023 | $0.00 | $-292.19M | — | — | — |
| 2024 | $67.42M | $-165.84M | 100.00% | -283.57% | -245.96% |
| 2025 | $0.00 | $-137.06M | — | — | — |